Your browser doesn't support javascript.
loading
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies.
Ritchlin, Christopher T; Mease, Philip J; Boehncke, Wolf-Henning; Tesser, John; Schiopu, Elena; Chakravarty, Soumya D; Kollmeier, Alexa P; Xu, Xie L; Shawi, May; Jiang, Yusang; Sheng, Shihong; Wang, Yanli; Xu, Stephen; Merola, Joseph F; McInnes, Iain B; Deodhar, Atul.
Afiliación
  • Ritchlin CT; Department of Medicine - Allergy/Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA christopher_ritchlin@urmc.rochester.edu.
  • Mease PJ; Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA.
  • Boehncke WH; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva, Switzerland.
  • Tesser J; Arizona Arthritis & Rheumatology Associates, Phoenix, Arizona, USA.
  • Schiopu E; Department of Rheumatology & Internal Medicine, Michigan Medicine Rheumatology Clinic, Ann Arbor, Michigan, USA.
  • Chakravarty SD; Immunology, Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, USA.
  • Kollmeier AP; Rheumatology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
  • Xu XL; Immunology, Janssen Research and Development LLC, San Diego, California, USA.
  • Shawi M; Immunology, Janssen Research and Development LLC, San Diego, California, USA.
  • Jiang Y; Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson and Johnson, Horsham, Pennsylvania, USA.
  • Sheng S; Biostatistics, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • Wang Y; Biostatistics, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • Xu S; Biostatistics, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • Merola JF; Biostatistics, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • McInnes IB; Dermatology and Medicine, Division of Rheumatology and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Deodhar A; Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, UK.
RMD Open ; 8(1)2022 03.
Article en En | MEDLINE | ID: mdl-35296534
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Psoriásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Psoriásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: RMD Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos